Document Detail

Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies.
MedLine Citation:
PMID:  5822598     Owner:  NLM     Status:  MEDLINE    
Increases or decreases of red cell glutathione reductase (GR) have been described in connection with many clinical abnormalities. We find that GR activity as measured in hemolysates represents only a portion of the available GR activity. The addition of small amounts of flavin adenine dinucleotide (FAD), but not of flavin mononucleotide or riboflavin, activates the GR of hemolysates. 1 muM FAD results in a maximal activation within 10 min; gradually increasing activation occurs at much lower, for example, 20 mmuM FAD concentrations. Once FAD has activated GR, dilution or dialysis does not reverse activation of the enzyme. Activation of GR by FAD can be inhibited by adenosine triphosphate (ATP), and to a lesser extent by adenosine diphosphate (ADP) and adenosine monophosphate (AMP), if these adenine nucleotides are added before the addition of FAD, but only to a slight extent if FAD is added before the adenine nucleotides. The addition of FAD to GR does not alter its electrophoretic mobility but produces intensification of the bands. The administration of 5 mg of riboflavin daily produces marked stimulation of red cell GR activity within only 2 days. After cessation of riboflavin administration, the GR activity again begins to fall. The degree of stimulation of GR activity by riboflavin is inversely correlated with the level of dietary riboflavin intake. The base line GR activity of normal individuals is directly correlated with the level of dietary riboflavin intake. The previously unexplained variations of glutathione reductase in health and disease must be reevaluated in light of the state of riboflavin nutrition and metabolism of the subject.
E Beutler
Related Documents :
6298918 - Taste bud adenosine -3'5'-monophosphate phosphodiesterase: activity, subcellular distri...
6433928 - On the inhibition of p-hydroxybenzoate hydroxylase from pseudomonas fluorescens by aden...
2991388 - Instability of succinyl ester linkages in o2'-monosuccinyl cyclic amp-protein conjugate...
201738 - Cyclic amp and the mechanism of leucocyte lysosomal enzyme release during an immediate ...
15556708 - Purification, characterization and functional analysis of an endo-arabinanase (abna) fr...
8147908 - Bestatin transport in rabbit intestinal brush-border membrane vesicles.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  48     ISSN:  0021-9738     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  1969 Oct 
Date Detail:
Created Date:  1969-11-26     Completed Date:  1969-11-26     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1957-66     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenine Nucleotides / pharmacology
Adenosine Triphosphate / pharmacology
Erythrocytes / enzymology*
Flavin Mononucleotide / pharmacology
Flavin-Adenine Dinucleotide / blood,  pharmacology
Glutathione Reductase / blood,  metabolism*
Middle Aged
Riboflavin / metabolism*,  therapeutic use*
Reg. No./Substance:
0/Adenine Nucleotides; 146-14-5/Flavin-Adenine Dinucleotide; 146-17-8/Flavin Mononucleotide; 56-65-5/Adenosine Triphosphate; 83-88-5/Riboflavin; EC Reductase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stimulation of insulin secretion by infusion of free fatty acids.
Next Document:  Social class gradients and serum uric acid in males and females.